Number of the records: 1
daklizumab
SYS d000077561 LBL 00000nx^^^2200181-^^45^^ 005 20240119195330.6 100 $a 20190101asloy0103 ba0 152 $b mesh 250 $a daklizumab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2019 (1995) $8 eng 330 1-
$a An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS. $8 eng 450 $a dakliximab $5 e $8 slo 450 $a Zenapax $5 e $8 slo 450 $a Zinbryta $5 e $8 slo 686 $a D12.776.124.486.485.114.224.060.766 686 $a D12.776.124.790.651.114.224.060.766 686 $a D12.776.377.715.548.114.224.200.766 750 $a Daclizumab $8 eng 801 -0
$a SK $b BA006 $c 20190310 801 -2
$a SK $b BA006 $c 20190417 980 $x M
Number of the records: 1